Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma
- 1 July 2008
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 21 (7), 817-825
- https://doi.org/10.1038/modpathol.2008.37
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Glypican-3: From the mutations of Simpson–Golabi–Behmel genetic syndrome to a tumor marker for hepatocellular carcinomaExperimental and Molecular Pathology, 2007
- The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinomaLaboratory Investigation, 2005
- Roles of heparan-sulphate glycosaminoglycans in cancerNature Reviews Cancer, 2002
- Glypican-3 expression is silenced in human breast cancerOncogene, 2001
- Glypicans: proteoglycans with a surpriseJCI Insight, 2001
- GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndromeAmerican Journal of Medical Genetics, 2001
- OCI-5/GPC3, a Glypican Encoded by a Gene That Is Mutated in the Simpson-Golabi-Behmel Overgrowth Syndrome, Induces Apoptosis in a Cell Line–specific MannerThe Journal of cell biology, 1998
- Expression of the Cell Surface Proteoglycan Glypican-5 Is Developmentally Regulated in Kidney, Limb, and BrainDevelopmental Biology, 1997
- Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndromeNature Genetics, 1996
- Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine.Molecular and Cellular Biology, 1988